Lymphocytes with Fc receptors (FcR) for IgG active in natural cytotoxicity and antibodydependent cellular cytotoxicity were separated into sheep erythrocyte rosetting (E+) and nonrosetting (E-) fractions, and examined for reactivity with the OK panel of hybridomaproduced monoclonal antibodies. Few cells in either the E+ FcR+ or the E-FcR+ fraction reacted with seven antibodies used to define T cells in various stages of differentiation (OK3, OKT4, OKT5, OKT6, OKT8, OKT9, OKT10). Neither fraction expressed an Ia-like antigen (detected by OKI1), but both were highly reactive with OKM1, an antibody that reacts with monocytes and granulocytes. Incubation of these cytotoxic effector cells with OKM1 plus complement abolished all cytotoxic reactivity, but incubation with a pan-T cell antibody (OKT3) plus complement had no significant effect. These cells were not monocyte precursors, because they could not be induced in vitro to develop macrophage characteristics. The data indicate that most cytotoxic effector cells in natural cytotoxicity and antibody-dependent cellular cytotoxicity are not in the T cell lineage, but have a myeloid origin.
A B S T R A C T Lymphocytes with Fc receptors (FcR)
for IgG active in natural cytotoxicity and antibodydependent cellular cytotoxicity were separated into sheep erythrocyte rosetting (E+) and nonrosetting (E-) fractions, and examined for reactivity with the OK panel of hybridoma-produced monoclonal antibodies. Few cells in either the E+ FcR+ or the E-FcR+ fraction reacted with seven antibodies used to define T cells in various stages of differentiation (OKT3, OKT4, OKT5, OKT6, OKT8, OKT9, OKTIO). Neither fraction expressed an Ia-like antigen (detected by OKI 1), but both were highly reactive with OKM 1, an antibody that reacts with monocytes and granulocytes. Incubation of these cytotoxic effector cells with OKM 1 plus complement abolished all cytotoxic reactivity, but incubation with a pan-T cell antibody (OKT3) plus complement had no significant effect. These cells were not monocyte precursors, because they could not be induced in vitro to develop macrophage characteristics. The data indicate that most cytotoxic effector cells in natural cytotoxicity and antibody-dependent cellular cytotoxicity are not in the T cell lineage, but have a myeloid origin. INTRODUCTION The precise lineage of blood lymphocytes that kill certain target cells in vitro without known prior sensitization to those targets (natural cytotoxicity, NC)' and of lymphocytes that kill immunoglobin G (IgG)-sensitized target cells (antibody-dependent cellular Received for publication 26 June 1980 and in revised form 28 July 1980. 'Abbreviations used in this paper: ADCC, antibody-dependent cellular cytotoxicity; BSA, bovine serum albumin; FcR, Fc receptors; L cells, C3 receptor-negative subset of non-T, non-B ("null") cells; NC, natural cytotoxicity. cytotoxicity, ADCC) is not well understood. Although it is agreed that lymphocytes with both NC and ADCC activities, when freshly isolated from blood, possess membrane Fe receptors (FcR) for IgG (1) , further characterization of these cells has been controversial. Originally, it was reported that the C3 receptor-negative subset of non-T, non-B ("null") cells (2), which we have called L cells (3) , were the cytotoxic effector cells. However, recent evidence has suggested that these cells may also have a T cell lineage. They have been shown to form rosettes with sheep erythrocytes (1, 4) , and, in other laboratories, their cytolytic activity has been abrogated by incubation with heterologous anti-T cell antisera and complement (5) . In this study, the relationship of cytotoxic effector cells to T cells was more precisely determined by isolating the FcRbearing effector cells in both the erythrocyte rosetting E+ and the nonrosetting E-fractions and examining them in parallel assays for NC and ADCC activities, as well as for reactivity with a panel of nine monoclonal antibodies that defined various stages in the developmental lineage of T cells (6) (7) (8) .
METHODDS
Peripheral blood lymphocytes. Procedures have been described (1, 4) to isolate mononuclear leukocytes from peripheral blood, to remove monocytes, and to separate lymphocytes that formed rosettes with sheep erythrocytes (E+ cells from E-cells). Greater than 95% of lymphocytes in El pellets formed rosettes, whereas only 4-6% of lymphocytes in the interface did so. Lymphocytes bearing highavidity FeR for IgG in the El and E-fractions were isolated by adherence to bovine serum albumin (BSA)-antiBSA immune complexes immobilized on plastic petri dishes, as previously described (9) . El cells with low-avidity FcR for IgG, and also B cells, did not adhere to these immunobilized complexes, as has already been reported (10) . Hence, FcR+ cells, as described in this report, only refer to cells bearing high-avidity FcR for IgG. Greater than 90% of the starting number of lymphocytes were recovered after these adherence procedures. 5-8% of the total E+ fraction were recovered in the FcR+ subset, whereas 40-60% of the Efraction were similarly recovered. Less than 2% of the EFcR+ cells expressed surface immunoglobulin, as was expected. Lymphocytes were stained with monoclonal antibodies while still bound to the immobilized complexes, or after they had detached spontaneously after overnight incubation on the complexes. Their reactivities with the antibodies were identical in both cases.
Monoclonal antibodies. The hybridoma-produced, monoclonal antibodies used in these studies were obtained from Doctors Patrick Kung and Gideon Goldstein, Ortho Pharmaceutical Corp., Raritan, N. J. The production, growth, and characterization of these antibodies have been the subjects of a series of recent reports (6, 7).
Immunofluorescence procedures. Detection of monocyte-macrophagelike cells. Cytocentrifuge preparations of each lymphocyte suspension were stained for a-naphthyl esterase, using a-naphthyl acetate as the substrate. Usually <1-2% of the cells were stained in these preparations. In addition, L cells and E+ cells bearing high-avidity FcR (Ty cells) were placed into culture for up to 9 d and examined daily for morphological changes, development of esterase reactivity, and capacity to ingest 0.81-,um latex particles (Difco Laboratories, Detroit, Mich.). Less than 1% of the cultured cells were macrophages by any of these criteria.
Cytotoxicity assays. The 4 h 5'Cr release assay was performed exactly as described (1), using 5'Cr-labeled K562 cells for the NC assay, and antibody-sensitized Chang cells for the ADCC assay. Cytotoxicity was expressed as lytic units. One lytic unit represented the number of effector cells required to release 30% of the 51Cr from the target cells, as previously described (1).
Complement-mediated lymphocytolysis was performed by incubating 6-7 x 106 lymphocytes in 100 ,ul of medium (RPMI 1640 containing 0.3% BSA and no Hepes buffer) with 200 ,ul of either OKT3 antibody (final dilution 1:100), OKM1 antibody (final dilution 1:20), or medium alone. After 60 min at 4°C, treated cells were washed once, incubated for 120 min at 37°C with a 1:8 final dilution of rabbit complement (Pel-Freeze Biologicals, Inc., Rogers, Ark.). Less than 5% of the starting number of immunofluorescent cells remained after reaction with antibody and complement.
When percent recovery of viable cells was determined, only from 30-40% of the cells treated with OKT3 and complement were recovered, whereas >80% of the cells treated with OKM 1 and complement remained viable.
RESULTS
Consistent with earlier reports (1, 4), Table I shows that NC and ADCC activities were found in both the E+ (Ty) and the E-(non-T) fractions of freshly isolated peripheral blood lymphocytes. When each fraction was adjusted to the same number of effector cells per tar- FcR-cells increased from 82 to 95% (P = 0.01, Wilcoxon rank-sum test). As expected, <2% of the E-FcR+ cells reacted with the anti-T cell monoclonal antibodies. Thus, both E+ and E-cytotoxic effector cells were similar in their very weak or negative reactivity with the panel of monoclonal antibodies used to define various T cell subsets.
There were other similarities between the E+ FcR+ and the E-FcR+ subsets. Less than 10% of both reacted with OKT10, which detects an antigen found on T lineage cells from prothymocytes to thymocytes (6, 7) , while <5% ofeither subset expressed an Ia-like antigen detected by OKI1, an antibody that reacts with B cells and monocytes (6) . Both E+ and E-cytotoxic effector cells were enriched in cells reacting with OKM1, an antibody that reacts with both monocytes and granulocytes (8) . Since (1:20 final dilution) and complement significantly inhibited NC activity against K562 cells, whereas incubation with OKM1 alone, OKT3 alone, or OKT3 plus complement was ineffective. When antibodycoated Chang cells were used as targets in ADCC, results identical to those obtained in the NC assays were obtained (data not shown). Because reactivity with OKM1 raised the possibility of monocyte lineage for the effector cells, E+ FcR+ and E-FcR+ cells were cultured in vitro for up to 9 d and examined at 3-d intervals for the ability to ingest latex particles, and for diffuse staining by a-naphthyl esterase. Less than 1% of these cells possessed either of these characteristics.
DISCUSSION
The results of the present study indicate that most FcR+ cytotoxic effector cells in NC and ADCC, while present in both the E+ and the E-fractions of peripheral blood, are not in the T cell lineage, as defined by the OK panel of hybridoma-produced monoclonal antibodies. These effector cells do, however, express an antigen (identified by the OKM1 antibody) that is pot present on the FcR-fractions ofblood lymphocytes that lack cytolytic activity.
As reported elsewhere (6) (7) (8) 
